- Home
- HAFN vs ASH Comparison
HAFN vs ASH Comparison
Compare HAFN & ASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAFN
- ASH
- Stock Information
- Founded
- HAFN 2012
- ASH 1924
- Country
- HAFN Bermuda
- ASH United States
- Employees
- HAFN N/A
- ASH N/A
- Industry
- HAFN
- ASH Specialty Chemicals
- Sector
- HAFN
- ASH Consumer Discretionary
- Exchange
- HAFN Nasdaq
- ASH Nasdaq
- Market Cap
- HAFN 4.0B
- ASH 4.1B
- IPO Year
- HAFN N/A
- ASH N/A
- Fundamental
- Price
- HAFN $7.24
- ASH $85.19
- Analyst Decision
- HAFN Strong Buy
- ASH Strong Buy
- Analyst Count
- HAFN 1
- ASH 8
- Target Price
- HAFN $10.00
- ASH $102.86
- AVG Volume (30 Days)
- HAFN 1.2M
- ASH 377.2K
- Earning Date
- HAFN 01-01-0001
- ASH 11-06-2024
- Dividend Yield
- HAFN 22.39%
- ASH 1.92%
- EPS Growth
- HAFN N/A
- ASH N/A
- EPS
- HAFN 1.56
- ASH 2.92
- Revenue
- HAFN $2,970,261,000.00
- ASH $2,108,000,000.00
- Revenue This Year
- HAFN N/A
- ASH N/A
- Revenue Next Year
- HAFN N/A
- ASH $2.00
- P/E Ratio
- HAFN $4.56
- ASH $29.06
- Revenue Growth
- HAFN 18.39
- ASH N/A
- 52 Week Low
- HAFN $6.85
- ASH $70.82
- 52 Week High
- HAFN $8.99
- ASH $102.50
- Technical
- Relative Strength Index (RSI)
- HAFN N/A
- ASH 40.55
- Support Level
- HAFN N/A
- ASH $82.64
- Resistance Level
- HAFN N/A
- ASH $90.61
- Average True Range (ATR)
- HAFN 0.00
- ASH 1.57
- MACD
- HAFN 0.00
- ASH -0.11
- Stochastic Oscillator
- HAFN 0.00
- ASH 32.00
About HAFN Hafnia Limited Common Shares
Hafnia Ltd is a shipping company. It provides transportation of oil and oil products and also owns and operates oil product tankers. It offers fleet and bunkers services. The group operates through four segments namely LR2 Product Tankers, LR1 Product Tankers, MR and Chemical-MR segment, and Handy and Chemical-Handy segment. It generates maximum revenue from the LR1 Product Tankers segment.
About ASH Ashland Inc.
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. Ashland includes only U.S. and Canada in its North America designation and includes Europe, the Middle East and Africa in its Europe designation.